Losartan and Losartan/HCTZ recall - AvKare

On April 25th 2019, AvKare announced an expanded recall on specific lots of Losartan 25mg tabs, Losartan/HCTZ 100/12.5mg tabs, and Lostartan/HCTZ 50/12.5mg tabs due to the detection of an unexpected impurity found in the active pharmaceutical ingredient manufactured by Hetero Labs Limited.

Losartan/HCTZ 100/12.5 - lot 19326, exp 3/31/19, NDC 5026851415
Losartan/HCTZ50/12.5 - lot 19454, exp 4/30/19, NDC 50268051315
Losartan 50mg - lot 19554, exp4/30/19, NDC 50268051615
Losartan 50mg - lot 20961, exp 9/30/19, NDC 50268051715
Losartan 50mg - lot 20477, exp 8/31/19, NDC 50268051715
Losartan 50mg - lot 20121, exp 6/30/19, NDC 50268051715